Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Assets (2017 - 2025)

Inspire Medical Systems' Assets history spans 9 years, with the latest figure at $907.3 million for Q4 2025.

  • For Q4 2025, Assets rose 12.24% year-over-year to $907.3 million; the TTM value through Dec 2025 reached $907.3 million, up 12.24%, while the annual FY2025 figure was $907.3 million, 12.24% up from the prior year.
  • Assets for Q4 2025 was $907.3 million at Inspire Medical Systems, up from $807.7 million in the prior quarter.
  • Across five years, Assets topped out at $907.3 million in Q4 2025 and bottomed at $272.2 million in Q2 2021.
  • The 5-year median for Assets is $628.9 million (2023), against an average of $578.3 million.
  • The largest annual shift saw Assets rose 0.33% in 2021 before it skyrocketed 111.73% in 2023.
  • A 5-year view of Assets shows it stood at $295.1 million in 2021, then skyrocketed by 91.43% to $564.9 million in 2022, then increased by 19.82% to $676.8 million in 2023, then grew by 19.44% to $808.4 million in 2024, then grew by 12.24% to $907.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Assets are $907.3 million (Q4 2025), $807.7 million (Q3 2025), and $802.2 million (Q2 2025).